Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy.

Ann Hematol · 2008 · PMC2275304 · PMID 18299833

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendp = 0.058so close (0.05 < p ≤ 0.1)

Using the UK dataset, reduced survival was significantly associated with a higher Ann Arbor disease stage (hazard ratio (HR) at treatment initiation 2.59 per stage increase by 1, 95% CI 1.45–4.66, p = 0.001) and showed a trend towards association with age (HR 1.02 per year of age, CI 1.00–1.04, p = 0.058) and RDI ≤ 90% (HR 1.42, CI 0.88–2.28, p = 0.146).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.